Diagnosis Solutions for Sepsis - Medical / Health Care
Sepsis is one of the leading causes of death worldwide. It is a life-threatening condition caused by a dysregulated host response to infection, which can progress to multiple organ dysfunction, septic shock and even death 1. Every hour counts in sepsis. It’s a medical emergency that requires immediate diagnosis because any delay in treatment can dramatically reduce the chances of survival 2.
-
Most popular related searches
Details
Sepsis early warning signs and symptoms, such as fever, chills, nausea, fatigue, pain, etc., are generic and non-specific, making it extremely challenging to differentiate sepsis from other conditions.
However, research shows that the early detection of sepsis with timely, appropriate interventions increases the likelihood of survival.
PSP is a protein biomarker produced by the pancreas and secreted in response to sepsis-related organ dysfunction.
PSP has shown great accuracy as an early warning sign of sepsis, increasing up to 3 days before overt clinical signs and symptoms appear 3. Abionic brings together an ultra-rapid nanofluidic-based diagnostic platform and the PSP biomarker to offer a unique bedside test for the earliest and immediate detection of sepsis. Its availability at the point of care (POC) on the abioSCOPE® device will enable the timely initiation of optimal treatments, thanks to a more accurate identification of sepsis.
Listen to the experts :how does Pancreatic Stone Protein (PSP) enable the early detection of sepsis in critically ill patients?
Curious to learn more?Discover how multiple clinical studies have demonstrated the clinical benefits of PSP.
Related product
Videos related to this application
-
Abionic Webinar - Advancing the Diagnosis of Sepsis in the Intensive Care Units. - Video
Real World Evidence for Implementing PSP measurements at the Point-of-Care.
Advancing the Diagnosis of Sepsis in the Intensive Care Units.
Re-watch our webinar from September 22nd 2021 to learn how experts in the field have been using the Pancreatic Stone Protein (PSP) biomarker to improve the management of critically ill patients at risk of sepsis. Discover data demonstrating the clinical benefit of serial bedside PSP measurements presen
